Innovation

ELM Utility Services: Major Growth Investment Raised For Supporting National Expansion

By Amit Chowdhry ● Nov 19, 2025

Tiger Infrastructure Partners has completed a significant growth investment in ELM Utility Services, a United States-based provider of outsourced public utility locating services. The investment is described as transformational for the company and positions ELM to accelerate its already significant growth nationwide.

The Partner Companies Secures Over $100 Million Strategic Investment From Tensile To Accelerate Manufacturing Expansion

By Amit Chowdhry ● Nov 19, 2025

The Partner Companies have secured a strategic equity investment exceeding $100 million from Tensile Capital Management, completing a capital raise that now totals more than $300 million. The funding includes the company’s recently closed syndicated credit facility of more than $200 million, led by Huntington Bank, marking a significant expansion phase for the U.S. advanced manufacturing group.

Roadrunner Venture Studios And Qunnect Unveil ABQ-Net, New Mexico’s First Quantum Network

By Amit Chowdhry ● Nov 19, 2025

Roadrunner Venture Studios and Qunnect have unveiled ABQ-Net, New Mexico’s first quantum network, marking a significant step in the state’s multi-year effort to build a competitive quantum economy. The launch reflects a broader $300 million state commitment to growing the sector. It aligns with a $25 million public investment dedicated to accelerating the commercialization of quantum technology and attracting top scientific talent to the region.

Portal26: Interview With CEO Arti Raman About The Enterprise GenAI Adoption Company

By Amit Chowdhry ● Nov 19, 2025

Portal26 is a company focused on helping large organizations adopt and manage generative AI in a secure, governed, and optimized way. Pulse 2.0 interviewed Portal26 CEO Arti Raman to gain a deeper understanding of the company.

Lucid Software: Interview With VP of Strategy & Operations Jamie Lyon About The Visual Collaboration And Workplace Acceleration Company

By Amit Chowdhry ● Nov 19, 2025

Lucid Software is a workplace acceleration company that provides a cloud-based visual collaboration platform for diagramming, whiteboarding, and process mapping. Pulse 2.0 interviewed Lucid VP of Strategy & Operations Jamie Lyon, Sr. to gain a deeper understanding of the company.

OptimHire: Interview With Founder & CEO Larry Kodali About The Recruitment Company

By Amit Chowdhry ● Nov 19, 2025

Nudge Security: $22.5 Million Series A Raised To Advance Workforce AI And SaaS Governance

By Amit Chowdhry ● Nov 19, 2025

Nudge Security has raised $22.5 million in Series A financing as the Austin-based company accelerates its mission to secure AI and SaaS usage at the Workforce Edge. Cerberus Ventures led the new funding round with additional participation from Ballistic Ventures, Forgepoint Capital, and Squadra Ventures. Alongside the investment, Cerberus Ventures Director Morgan Mahlock will join the company’s board.

LineLeap: Over $30 Million At $200 Million Valuation Raised For Brand Experience Platform

By Amit Chowdhry ● Nov 19, 2025

LineLeap, a platform redefining how people access nightlife venues and brand experiences, announced the closure of its latest funding round, bringing the company’s valuation to $200 million and lifting its total capital raised to over $30 million.

Jiga: $12 MIllion Series A Closed For AI-Era Hardware Sourcing

By Amit Chowdhry ● Nov 19, 2025

Platform provider Jiga announced the closing of a $12-million Series A funding round, led by Aleph with participation from seed-round backer Symbol and accelerator Y Combinator. The capital injection arrives as Jiga scales into sourcing bottlenecks that hardware and AI companies face when procuring custom physical parts for aerospace, defense, robotics, and other advanced sectors.

VenstraMedical: Strategic Investment Raised To Drive Next-Generation Cardiac Support Device Development

By Amit Chowdhry ● Nov 19, 2025

Cardiovascular medical-device company VenstraMedical today announced a significant investment from Minnesota-based venture capital firm Highcroft Capital, which will accelerate the company’s development of its next-generation percutaneous ventricular assist device (pVAD). The funding underscores VenstraMedical’s ambition to transform temporary mechanical circulatory support for patients in cardiogenic shock or undergoing high-risk coronary interventions.

Lifordi Immunotherapeutics: Strategic Investment Raised As Sanofi Ventures Joins $112 Million Round

By Amit Chowdhry ● Nov 19, 2025

Clinical-stage biotech company Lifordi Immunotherapeutics, which is focused on developing antibody-drug conjugates (ADCs) for autoimmune and inflammatory disorders, announced that it has secured a strategic investment from Sanofi Ventures — the venture-capital arm of global healthcare company Sanofi — alongside additional funding from its existing investors including ARCH Ventures, 5AM Ventures, and Atlas Venture. The funding brings Lifordi’s total capital raised to $112 million to date.

Bitfury Launches $1 Billion Funding Initiative To Advance Ethical Emerging Technologies

By Amit Chowdhry ● Nov 19, 2025

Bitfury has launched a $1 billion funding initiative as part of its transformation from a bitcoin-mining pioneer into a global investment firm focused on accelerating ethical and human-centric emerging technologies. The company plans to begin deploying capital as early as the fourth quarter of 2025.

Shakers: Interview With Co-Founder & CEO Héctor Mata About The Freelance Talent Marketplace Company

By Amit Chowdhry ● Nov 19, 2025

Shakers is a platform that connects companies with curated freelance talent for project-based work. Pulse 2.0 interviewed Shakers co-founder and CEO Héctor Mata to gain a deeper understanding of the company.

Captain T Cell: €20 Million Funding Raised To Propel Next-Gen Solid Tumor TCR-T Programs Into Clinic

By Amit Chowdhry ● Nov 19, 2025

Biotech firm Captain T Cell announced today the successful closing of an equity financing round, bringing its total available funding to €20 million, together with previously secured grants. The funds are earmarked to drive the company's proprietary pipeline—specifically its lead autologous TCR-T program, CTC127, into a first-in-human Phase I trial, and push its allogeneic “off-the-shelf” TCR-T platform toward clinical readiness.